Low Estradiol May Not Impede Cognitive Restructuring in Women With Anxiety Disorders.

anxiety cognitive restructuring estradiol psychophysiological assessment

Journal

Journal of cognitive psychotherapy
ISSN: 1938-887X
Titre abrégé: J Cogn Psychother
Pays: United States
ID NLM: 8806397

Informations de publication

Date de publication:
01 08 2021
Historique:
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 29 10 2021
Statut: ppublish

Résumé

Prior research suggests that estradiol may moderate fear extinction in animal models and humans. Based on these findings, estradiol may also moderate cognitive reappraisal, which is theorized to be an important mechanism of change in extinction-based therapy (exposure therapy). We compared cognitive restructuring (CR) skills acquisition and outcome between women with primary anxiety disorders who had high versus low estradiol using a standardized CR task that closely resembles clinical practice. As a proxy of CR outcome, we assessed subjective distress ratings before and after the task and psychophysiological arousal (heart rate and electrodermal activity) throughout the task. Contrary to predictions, results showed that CR skills acquisition and outcome did not differ between the high and low estradiol groups. Although both groups demonstrated reductions in negative affect and skin conductance responses during the CR task, suggesting that participants were able to acquire CR skills and use them effectively to regulate distress, the groups did not differ with respect to CR ability or outcome. The findings suggest that estradiol may not moderate cognitive reappraisal, and may have more of an effect on basic habituation and extinction processes instead.

Identifiants

pubmed: 34362860
pii: JCPSY-D-20-00038
doi: 10.1891/JCPSY-D-20-00038
doi:

Substances chimiques

Estradiol 4TI98Z838E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

212-220

Informations de copyright

© Copyright 2021 Springer Publishing Company, LLC.

Auteurs

Hannah C Levy (HC)

Anxiety Disorders Center, Institute of Living, Hartford, CT hannah.levy@hhchealth.org.

Anishka Jean (A)

Anxiety Disorders Center, Institute of Living, Hartford, CT.

Terence H W Ching (THW)

Anxiety Disorders Center, Institute of Living, Hartford, CT.

Alyssa Nett (A)

Anxiety Disorders Center, Institute of Living, Hartford, CT.

Jessica Mullins (J)

Department of Obstetrics & Gynecology, Hartford Hospital, Hartford, CT.

David F Tolin (DF)

Anxiety Disorders Center, Institute of Living, Hartford, CT.
Yale University School of Medicine, New Haven, CT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH